FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster.
The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website.
By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser .
Research Articles Abstract - 2012 Issues Archive
[Source: AMEDEO, hompage:
http://www.amedeo.com .]
Research Articles Abstracts?January 1 2012 Issue
Abstracts List
KIM M, Yim JH, Kim SY, Kim HS, et al.
LEE SM, Gai WW, Cheung TK, Peiris JS, et al.
BANTIA S, Upshaw R, Babu YS.
LIU Q, Ma J, Liu H, Qi W, et al.
ROEHR B.
CARD AJ.
DUNNING J, Nguyen-Van-Tam J, Nicholson K, Openshaw P, et al.
BEHRMAN AJ, Caplan AL, Coffin SE, Fishman N, et al.
VAN TT, Miller J, Warshauer DM, Reisdorf E, et al.
KRAFT CS, Jacob JT, Sears MH, Burd EM, et al.
IP DK, Schutten M, Fang VJ, Fung RO, et al.
SUGUITAN AL JR, Matsuoka Y, Lau YF, Santos CP, et al.
The multi-basic cleavage site of the hemagglutinin of the highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals.
J Virol. 2011.
http://amedeo.com/p2.php?id=22205751&s=flu&pm=2
ABSTRACT available
BETTS RJ, Prabhu N, Ho AW, Lew FC, et al.
SHEHATA AA, Fiebig P, H Sultan, Hafez M, et al.
Development of a recombinant ELISA using yeast (Pichia pastoris)-expressed polypeptides for detection of antibodies against avian influenza A subtype H5.
J Virol Methods. 2011.
http://amedeo.com/p2.php?id=22197190&s=flu&pm=2
ABSTRACT available
HURT AC, Hardie K, Wilson NJ, Deng YM, et al.
PYO HM, Masic A, Woldeab N, Embury-Hyatt C, et al.
NEWES-ADEYI G, Greece J, Bozeman S, Walker DK, et al.
WILLIAMS TL, Pirkle JL, Barr JR.
PIZZORNO A, Abed Y, Bouhy X, Beaulieu E, et al.
Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level and virulence of the 2009 pandemic influenza virus.
Antimicrob Agents Chemother. 2011.
http://amedeo.com/p2.php?id=22203589&s=flu&pm=2
ABSTRACT available
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
-------
Research Articles Abstracts?January 7 2012 Issue
Research Articles Abstracts?January 7 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?January 7 2012 Issue
Abstracts List
ELKIN PL, Froehling DA, Wahner-Roedler DL, Brown SH, et al.
CLOUTIER A, Marois I, Cloutier D, Verreault C, et al.
?
?
?
BRIEN S, Kwong JC, Buckeridge DL.
YIM K, Miles B, Zinsou R, Prince G, et al.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
------
Research Articles Abstracts?January 14 2012
Research Articles Abstracts?January 14 2012
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?January 14 2012
Abstracts List
Ohkura T, Kikuchi Y, Kono N, Itamura S, et al.
Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
Biochem Biophys Res Commun. 2011.
PubMed - Related Articles
Abstract available
Hu H, Voss J, Zhang G, Buchy P, et al.
A Human Antibody Recognizing a Conserved Epitope of H5 Hemagglutinin Broadly Neutralizes Highly Pathogenic Avian Influenza H5N1 Viruses.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Hu Y, Jin Y, Han D, Zhang G, et al.
Mast cell-induced lung injury in mice infected with H5N1 influenza virus.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Punnoose AR, Golub RM.
Liu WM, Nahar TE, Jacobi RH, Gijzen K, et al.
Impaired production of TNF-alpha by dendritic cells of older adults leads to a lower CD8+ T cell response against influenza.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Lekcharoensuk P, Wiriyarat W, Petcharat N, Lekcharoensuk C, et al.
Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Reed C, Meltzer MI, Finelli L, Fiore A, et al.
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Chiu SS, Chan KH, So LY, Chen R, et al.
The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Dwyer DE.
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.
Vaccine. 2011;29 Suppl 2:B56-62.
PubMed - Related Articles
Abstract available
Simonsen L, Viboud C, Chowell G, Andreasen V, et al.
The need for interdisciplinary studies of historic pandemics.
Vaccine. 2011;29 Suppl 2:B1-5.
PubMed - Related Articles
-
-------
Research Articles Abstracts?January 21 2012 Issue
Research Articles Abstracts?January 21 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?January 21 2012 Issue
Abstracts List
Wang CZ, Li P, Yuan CS.
Traditional Chinese Herbal Therapy as a Treatment Option for H1N1 Influenza.
Ann Intern Med. 2012;156:166.
PubMed - Related Articles
Stoner TD, Krauss S, Turner JC, Seiler P, et al.
Susceptibility of avian influenza viruses of the N6 subtype to the neuraminidase inhibitor oseltamivir.
Antiviral Res. 2012.
PubMed - Related Articles
Abstract available
Koerner I, Matrosovich MN, Haller O, Staeheli P, et al.
Altered receptor specificity and fusion activity of the hemagglutinin contribute to high virulence of a mouse-adapted influenza A virus.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Bruce EA, Abbink TE, Wise HM, Rollason R, et al.
Release of filamentous and spherical influenza A virus is not restricted by tetherin.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Nicol MQ, Ligertwood Y, Bacon MN, Dutia BM, et al.
A novel family of peptides with potent activity against influenza A viruses.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Diaz E, Martin-Loeches I, Canadell L, Vidaur L, et al.
Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza.
J Infect. 2012.
PubMed - Related Articles
Abstract available
Kanchana S, Kanchana S, Chuntrakul C, Malathum K, et al.
Pandemic (H1N1) 2009 virus infection: persistent viral shedding after Oseltamivir treatment.
J Infect. 2011;63:295-9.
PubMed - Related Articles
Abstract available
Choi SH, Chung JW, Jeon MH, Lee MS, et al.
Risk factors for pandemic H1N1 2009 infection in healthcare personnel of four general hospitals.
J Infect. 2011;63:267-73.
PubMed - Related Articles
Abstract available
Kobayashi Y, Suzuki Y.
Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Fontana J, Cardone G, Heymann JB, Winkler DC, et al.
Structural changes in influenza virus at low pH characterized by cryo-electron tomography.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Khurana S, Sasono P, Fox A, Nguyen VK, et al.
H5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.
J Virol. 2011;85:12455-63.
PubMed - Related Articles
Abstract available
Iorio AM, Bistoni O, Galdiero M, Lepri E, et al.
Influenza viruses and cross-reactivity in healthy adults: Humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Polisena J, Chen Y, Manuel D.
The proportion of influenza vaccination in Ontario, Canada in 2007/2008 compared with other provinces.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
-
-------
Research Articles Abstracts ? January 28 2012 Issue
Research Articles Abstracts ? January 28 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? January 28 2012 Issue
Abstracts List
Emborg HD, Krause TG, Hviid A, Simonsen J, et al.
Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.
BMJ. 2011;344:d7901.
PubMed - Related Articles
Abstract available
Keil U, Schonhofer P, Spelsberg A.
Re: Nicoll A, Sprenger M. learning lessons from the 2009 pandemic: putting infections in their proper place. Eur J Epidemiol 2011; 26:191-194.
Eur J Epidemiol. 2011;26:757-8.
PubMed - Related Articles
Arnott A, Vong S, Mardy S, Chu S, et al.
A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype.
J Clin Microbiol. 2011;49:3504-13.
PubMed - Related Articles
Abstract available
Hilton S, Hunt K.
UK newspapers' representations of the 2009-10 outbreak of swine flu: one health scare not over-hyped by the media?
J Epidemiol Community Health. 2011;65:941-6.
PubMed - Related Articles
Abstract available
El Sahly HM, Davis C, Kotloff K, Meier J, et al.
Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-Infected Adults: A Randomized Clinical Trial.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Lin SJ, Cheng PJ, Lin TY, Lee PT, et al.
Effect of Influenza A Infection on Umbilical Cord Blood Natural Killer Function Regulation With Interleukin-15.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Jennrich S, Lee MH, Lynn RC, Dewberry K, et al.
Tissue exit - a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza A virus-infected lung.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Chockalingam AK, Hickman D, Pena L, Ye J, et al.
Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza subtypes do not affect post-influenza secondary bacterial pneumonia.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Zang N, Xie X, Deng Y, Wu S, et al.
Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.
J Virol. 2011;85:13061-8.
PubMed - Related Articles
Abstract available
Heikkinen T, Heinonen S.
Ambrose CS, Belshe RB.
Veen RL, Loynachan AT, Mogler MA, Russell BJ, et al.
Safety, immunogenicity, and efficacy of an alphavirus replicon-based swine influenza virus hemagglutinin vaccine.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Ramsey MA, Marczinski CA.
College students' perceptions of H1N1 flu risk and attitudes toward vaccination.
Vaccine. 2011.
PubMed - Related Articles
Abstract available
Van Cleve WC, Christakis DA.
Unnecessary care for bronchiolitis decreases with increasing inpatient prevalence of bronchiolitis.
Pediatrics. 2011;128:e1106-12.
PubMed - Related Articles
Abstract available
Wishaupt JO, Russcher A, Smeets LC, Versteegh FG, et al.
Clinical impact of RT-PCR for pediatric acute respiratory infections: a controlled clinical trial.
Pediatrics. 2011;128:e1113-20.
PubMed - Related Articles
Abstract available
-
------
Research Articles Abstracts ? February 4 2012 Issue
Research Articles Abstracts ? February 4 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? February 4 2012 Issue
Abstracts List
Pavia AT.
Laboratory Creation of a Highly Transmissible H5N1 Influenza Virus: Balancing Substantial Risks and Real Benefits.
Ann Intern Med. 2012.
PubMed - Related Articles
Abstract available
Shi J, Wen Z, Guo J, Zhang Y, et al.
Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
Antiviral Res. 2012.
PubMed - Related Articles
Abstract available
Kosik I, Krejnusova I, Praznovska M, Polakova K, et al.
A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection.
Arch Virol. 2012.
PubMed - Related Articles
Abstract available
Stramer SL, Collins C, Nugent T, Wang X, et al.
Sensitive Detection Assays for Influenza RNA Do Not Reveal Viremia in US Blood Donors.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
McCullers JA, Hayden FG.
Fatal Influenza B Infections: Time to Reexamine Influenza Research Priorities.
J Infect Dis. 2012.
PubMed - Related Articles
Paddock CD, Liu L, Denison AM, Bartlett JH, et al.
Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Haeck JD, Dongelmans DA, Schultz MJ.
McElhaney JE, Zhou X, Talbot HK, Soethout E, et al.
The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Poland GA, Tosh PK.
-
-------
Research Articles Abstracts?February 11 2012
Research Articles Abstracts?February 11 2012
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?February 11 2012
Abstracts List
?
EARN DJ, He D, Loeb MB, Fonseca K, et al.
MENEGHESSO S, Vanderlinden E, Stevaert A, McGuigan C, et al.
RAFFEL JB, Al-Lawati A, Murch N.
BURKOM H, Kniss K, Meltzer M, Brammer L, et al.
FAN K, Jia Y, Wang S, Li H, et al.
FERGUSON M, Risi G, Davis M, Sheldon E, et al.
NEUZIL KM.
VAN STRY M, Oguin T, Cheloufi S, Vogel P, et al.
MEUNIER I, von Messling V.
PICA N, Chou YY, Bouvier NM, Palese P, et al.
VICTOR ST, Watanabe S, Katsura H, Ozawa M, et al.
WANG M, Tscherne DM, McCullough C, Caffrey M, et al.
PICA N, Hai R, Krammer F, Wang TT, et al.
PALESE P, Wang TT.
ONODERA T, Takahashi Y, Yokoi Y, Ato M, et al.
VEITS J, Weber S, Stech O, Breithaupt A, et al.
SHAMAN J, Lipsitch M.
MCNEIL MM, Arana J, Stewart B, Hartshorn M, et al.
FATIREGUN AA, Adeyemo AA, Olowookere SA.
BHAT-SCHELBERT K, Lin CJ, Matambanadzo A, Hannibal K, et al.
HAGGLUND S, Hu K, Vargmar K, Pore L, et al.
TAVARES F, Delaigle A, Slavin D, Bauchau V, et al.
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
------
Research Articles Abstracts?February 18 2012 Issue
Research Articles Abstracts?February 18 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?February 18 2012 Issue
Abstracts List
Palmore TN, Henderson DK.
Nguyen HT, Trujillo AA, Sheu TG, Levine M, et al.
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Antiviral Res. 2012.
PubMed - Related Articles
Abstract available
Ferraris O, Escuret V, Bouscambert M, Casalegno JS, et al.
H1N1 influenza A virus neuraminidase modulates infectivity in mice.
Antiviral Res. 2012.
PubMed - Related Articles
Abstract available
Pei D, Dai J, Kuang Y, Wang H, et al.
Effect of influenza A virus non-structural protein 1(NS1) on a mouse model of diabetes mellitus induced by Streptozotocin.
Biochem Biophys Res Commun. 2012.
PubMed - Related Articles
Abstract available
Shelton H, Smith M, Hartgroves LC, Stilwell P, et al.
An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Schibler M, Gerlach D, Martinez Y, Belle SV, et al.
Experimental human rhinovirus and enterovirus interspecies recombination.
J Gen Virol. 2012;93.
PubMed - Related Articles
Abstract available
Stout-Delgado HW, Vaughan SE, Shirali AC, Jaramillo RJ, et al.
Impaired NLRP3 Inflammasome Function in Elderly Mice during Influenza Infection Is Rescued by Treatment with Nigericin.
J Immunol. 2012.
PubMed - Related Articles
Abstract available
Harder KM, Molbak K, Glismann S, Christiansen AH, et al.
Influenza-associated illness is an important contributor to febrile convulsions in Danish children.
J Infect. 2012.
PubMed - Related Articles
Abstract available
Fritz R, Sabarth N, Kiermayr S, Hohenadl C, et al.
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies.
J Infect Dis. 2011.
PubMed - Related Articles
Abstract available
Powell TJ, Fox A, Peng Y, Quynh Mai le T, et al.
Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections.
J Infect Dis. 2012;205:20-7.
PubMed - Related Articles
Abstract available
Arinaminpathy N, Ratmann O, Koelle K, Epstein SL, et al.
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza.
Proc Natl Acad Sci U S A. 2012.
PubMed - Related Articles
Abstract available
Savard C, Laliberte-Gagne ME, Babin C, Bolduc M, et al.
Improvement of the PapMV nanoparticle adjuvant property through an increased of its avidity for the antigen [influenza NP].
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Macdonald LA, Aggarwal S, Bussey KA, Desmet EA, et al.
Molecular interactions and trafficking of influenza A virus polymerase proteins analyzed by specific monoclonal antibodies.
Virology. 2012.
PubMed - Related Articles
Abstract available
Miller EK, Bugna J, Libster R, Shepherd BE, et al.
Human Rhinoviruses in Severe Respiratory Disease in Very Low Birth Weight Infants.
Pediatrics. 2011.
PubMed - Related Articles
Abstract available
Perrin KM, Begue RE.
Use of palivizumab in primary practice.
Pediatrics. 2012;129:55-61.
PubMed - Related Articles
Abstract available
-
-------
Research Articles Abstracts?February 25 2012 Issue
Research Articles Abstracts?February 25 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?February 25 2012 Issue
Abstracts List
Hassan MK, Kilany WH, Abdelwhab EM, Arafa AS, et al.
Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.
Arch Virol. 2012.
PubMed - Related Articles
Abstract available
Roehr B.
van Doorn HR, Kinh NV, Tuan HM, Tuan TA, et al.
Clinical Validation of a Point-of-Care multiplexed in vitro immunoassay using monoclonal antibodies (MSD(R) Influenza Test) in 4 hospitals in Vietnam.
J Clin Microbiol. 2012.
PubMed - Related Articles
Abstract available
Ma W, Liu Q, Bawa B, Qiao C, et al.
The NA and M genes of the 2009 pandemic influenza H1N1 virus functionally cooperate to facilitate efficient replication and transmissibility in pigs.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Lycett S, McLeish NJ, Robertson C, Carman W, et al.
Origin and Fate of A/H1N1 Influenza in Scotland during 2009.
J Gen Virol. 2012.
PubMed - Related Articles
Abstract available
Caproni E, Tritto E, Cortese M, Muzzi A, et al.
MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action.
J Immunol. 2012.
PubMed - Related Articles
Abstract available
Doss M, Ruchala P, Tecle T, Gantz D, et al.
Hapivirins and Diprovirins: Novel theta-Defensin Analogs with Potent Activity against Influenza A Virus.
J Immunol. 2012.
PubMed - Related Articles
Abstract available
Trichereau J, Verret C, Mayet A, Manet G, et al.
Estimation of the reproductive number for A(H1N1)pdm09 influenza among the French armed forces, September 2009- March 2010.
J Infect. 2012.
PubMed - Related Articles
Gambaryan AS, Matrosovich TY, Philipp J, Munster VJ, et al.
Receptor-binding Profiles of H7 Subtype Influenza Viruses in Different Host Species.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Ayllon J, Hale BG, Garcia-Sastre A.
Strain-specific contribution of NS1-activated PI3K signaling to influenza A virus replication and virulence.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Seibert CW, Rahmat S, Krammer F, Palese P, et al.
Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Cao S, Liu X, Yu M, Li J, et al.
A Nuclear Export Signal in the Matrix Protein of Influenza A Virus Is Required for the Efficient Virus Replication.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Yu M, Liu X, Cao S, Zhao Z, et al.
Identification and Characterization of three novel nuclear export signals in influenza A virus nucleoprotein.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Fang J, Hao Q, Liu L, Li Y, et al.
Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.
J Virol. 2012;86:1010-20.
PubMed - Related Articles
Abstract available
Falah N, Violot S, Decimo D, Berri F, et al.
Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease.
J Virol. 2012;86:691-704.
PubMed - Related Articles
Abstract available
.. .
Update: influenza activity - United States, october 2, 2011-february 11, 2012.
MMWR Morb Mortal Wkly Rep. 2012;61:123-8.
PubMed - Related Articles
Abstract available
.. .
Influenza vaccination coverage among pregnant women - 29 States and new york city, 2009-10 season.
MMWR Morb Mortal Wkly Rep. 2012;61:113-8.
PubMed - Related Articles
Abstract available
Pearce MB, Jayaraman A, Pappas C, Belser JA, et al.
Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets.
Proc Natl Acad Sci U S A. 2012.
PubMed - Related Articles
Abstract available
Lei T, Siu KL, Kok KH, Chan KH, et al.
Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Lin TH, Lin SY, Lin CH, Lin RI, et al.
AdimFlu-S((R)) influenza A (H1N1) vaccine during pregnancy: The Taiwanese Pharmacovigilance Survey.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Ansaldi F, Canepa P, Ceravolo A, Valle L, et al.
Intanza((R)) 15 intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Nagy A, Cernikova L, Krivda V, Hornickova J, et al.
Digital genotyping of avian influenza viruses of H7 subtype detected in central Europe in 2007-2011.
Virus Res. 2012.
PubMed - Related Articles
Abstract available
-
------
Research Articles Abstracts?March 10 2012 Issue
Research Articles Abstracts?March 10 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?March 10 2012 Issue
Abstracts List
Maamary J, Pica N, Belicha-Villanueva A, Chou YY, et al.
Attenuated influenza virus construct with enhanced hemagglutinin protein expression.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Hai R, Krammer F, Tan GS, Pica N, et al.
Influenza viruses expressing chimeric hemagglutinins: Globular head and stalk domains derived from different subtypes.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Belicha-Villanueva A, Rodriguez-Madoz JR, Maamary J, Baum A, et al.
Recombinant influenza A viruses with enhanced PB1 and PA viral protein expression.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Noronha JM, Liu M, Squires RB, Pickett BE, et al.
Influenza Sequence Feature Variant Type (Flu-SFVT) analysis: evidence for a role of NS1 in influenza host range restriction.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Tang Q, Wang J, Bao J, Sun H, et al.
A multiplex RT-PCR assay for detection and differentiation of avian H3, H5, and H9 subtype influenza viruses and Newcastle disease viruses.
J Virol Methods. 2012.
PubMed - Related Articles
Abstract available
Gorai T, Goto H, Noda T, Watanabe T, et al.
F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding.
Proc Natl Acad Sci U S A. 2012.
PubMed - Related Articles
Abstract available
Sylte MJ, Suarez DL.
Vaccination and acute phase mediator production in chickens challenged with low pathogenic avian influenza virus; novel markers for vaccine efficacy?
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Xu J, Huang D, Liu S, Lin H, et al.
Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Yin JK, Chow MY, Khandaker G, King C, et al.
Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Fedorova AA, Goncharova EP, Kovpak MP, Vlassov VV, et al.
Influenza virus inactivated by artificial ribonucleases as a prospective killed virus vaccine.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Baxter R, Toback SL, Sifakis F, Hansen J, et al.
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
He CQ, Ding NZ, Mou X, Xie ZX, et al.
Identification of three H1N1 influenza virus groups with natural recombinant genes circulating from 1918 to 2009.
Virology. 2012.
PubMed - Related Articles
Abstract available
Keane VA, Hudson AR, King JC Jr.
Pediatrician Attitudes Concerning School-located Vaccination Clinics for Seasonal Influenza.
Pediatrics. 2012;129 Suppl 2:S96-S100.
PubMed - Related Articles
Abstract available
Cummings GE, Ruff E, Guthrie SH, Hoffmaster MA, et al.
Successful Use of Volunteers to Conduct School-located Mass Influenza Vaccination Clinics.
Pediatrics. 2012;129 Suppl 2:S88-95.
PubMed - Related Articles
Abstract available
Schieber RA, Kennedy A, Kahn EB.
Early Experience Conducting School-located Vaccination Programs for Seasonal Influenza.
Pediatrics. 2012;129 Suppl 2:S68-74.
PubMed - Related Articles
Abstract available
Longini IM Jr.
A theoretic framework to consider the effect of immunizing schoolchildren against influenza: implications for research.
Pediatrics. 2012;129 Suppl 2:S63-7.
PubMed - Related Articles
Abstract available
E Fiore A, Epperson S, Perrotta D, Bernstein H, et al.
Expanding the recommendations for annual influenza vaccination to school-age children in the United States.
Pediatrics. 2012;129 Suppl 2:S54-62.
PubMed - Related Articles
Abstract available
Neuzil KM, Fiore AE, Schieber RA.
Evolution of the pediatric influenza vaccination program in the United States.
Pediatrics. 2012;129 Suppl 2:S51-3.
PubMed - Related Articles
Vogt TM, Wortley PM.
Epilogue: School-located Influenza Vaccination During the 2009-2010 Pandemic and Beyond.
Pediatrics. 2012;129 Suppl 2:S107-9.
PubMed - Related Articles
Fishbane M, Kist A, Schieber RA.
Use of the Emergency Incident Command System for School-located Mass Influenza Vaccination Clinics.
Pediatrics. 2012;129 Suppl 2:S101-6.
PubMed - Related Articles
Abstract available
-
-------
Research Articles Abstracts ? March 17 2012 Issue
Research Articles Abstracts ? March 17 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? March 17 2012 Issue
Abstracts List
MOON HJ, Lee JS, Choi YK, Park JY, et al.
ZHOU JP, Ge FF, Liu J, Ju HB, et al.
KASSON PM.
MURRAY EL, Khagayi S, Ope M, Bigogo G, et al.
MURRAY EL, Klein M, Brondi L, McGowan JE Jr, et al.
SURESH PS, Rajan T, Thejaswini V, Kannan R, et al.
DE MIGUEL-DIEZ J, Carrasco-Garrido P, Hernandez-Barrera V, Rodriguez-Rodriguez P, et al.
KAHN JS.
IOANNIDIS LJ, Verity EE, Crawford S, Rockman SP, et al.
SHEN X, Soderholm J, Lin F, Kobinger G, et al.
O'CONNOR ME, Everhart RM, Berg M, Federico SG, et al.
TAKANASHI JI, Takahashi Y, Imamura A, Kodama K, et al.
-
-------
Research Articles Abstracts ? March 24 2012 Issue
Research Articles Abstracts ? March 24 2012 Issue
[Source: AMEDEO, hompeage: (
LINK ).]
Research Articles Abstracts ? March 24 2012 Issue
Abstracts List
TARBET EB, Maekawa M, Furuta Y, Babu YS, et al.
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
EL-ZOGHBY EF, Arafa AS, Hassan MK, Aly MM, et al.
Isolation of H9N2 avian influenza virus from bobwhite quail (Colinus virginianus) in Egypt.
ROEHR B.
US board says censuring research on avian flu was necessary to prevent a potential catastrophe.
KIM HR, Park CK, Lee YJ, Oem JK, et al.
Low pathogenic H7 subtype avian influenza viruses isolated from domestic ducks in South Korea and the close association with isolates of wild birds.
BOIVIN GA, Pothlichet J, Skamene E, Brown EG, et al.
Mapping of Clinical and Expression Quantitative Trait Loci in a Sex-Dependent Effect of Host Susceptibility to Mouse-Adapted Influenza H3N2/HK/1/68.
LOVEDAY EK, Svinti V, Diederich S, Pasick J, et al.
Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection.
HUANG K, Zhu H, Fan X, Wang J, et al.
Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China.
JANG YH, Byun YH, Lee YJ, Lee YH, et al.
Cold-adapted pandemic 2009 H1N1 influenza live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses.
LI F, Zhu H, Sun R, Wei H, et al.
Natural killer cells are involved in acute lung immune injury caused by respiratory syncytial virus infection.
FAN X, Zhu H, Zhou B, Smith DK, et al.
Emergence and dissemination of a swine H3N2 reassortant influenza virus with 2009 pandemic H1N1 genes in pigs in China.
FANG Y, Banner D, Kelvin AA, Huang SS, et al.
Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.
CHENG LW, Huang SW, Huang LM, Chang LY, et al.
Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine.
CHANDLER DP, Griesemer SB, Cooney CG, Holmberg R, et al.
Rapid, simple influenza RNA extraction from nasopharyngeal samples.
KUEHN BM.
SHAIKH AG, Termsarasab P, Nwankwo C, Rao-Frisch A, et al.
Atypical forms of Guillain-Barre syndrome and H1N1-influenza vaccination.
BAXTER R, Toback SL, Sifakis F, Hansen J, et al.
A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.
SEYLER T, Bella A, Puzelli S, Donatelli I, et al.
Estimating pandemic vaccine effectiveness in two Italian regions using the screening method, 2009-2010.
-
-------
Research Articles Abstracts?March 31 2012 Issue
Research Articles Abstracts?March 31 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?March 31 2012 Issue
Abstracts List
Nair H, Holmes A, Rudan I, Car J, et al.
Wythe SE, Dodd JS, Openshaw PJ, Schwarze J, et al.
OX40 ligand and programmed cell death 1 ligand 2 expression on inflammatory dendritic cells regulates CD4 T cell cytokine production in the lung during viral disease.
J Immunol. 2012;188:1647-55.
PubMed - Related Articles
Abstract available
Spolski R, Wang L, Wan CK, Bonville CA, et al.
IL-21 promotes the pathologic immune response to pneumovirus infection.
J Immunol. 2012;188:1924-32.
PubMed - Related Articles
Abstract available
Qin G, Liu Y, Zheng J, Xiang Z, et al.
Phenotypic and functional characterization of human gammadelta T cell subsets in response to influenza A viruses.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Hirsch MS.
Osterholm MT, Relman DA.
Creating a Mammalian Transmissible A/H5N1 Influenza Virus: Social Contracts, Prudence, and Alternative Perspectives.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Perelson AS, Rong L, Hayden FG.
Combination Antiviral Therapy for Influenza: Predictions from Modeling of Human Infections.
J Infect Dis. 2012.
PubMed - Related Articles
Abstract available
Overton ET.
Krause JC, Tsibane T, Tumpey TM, Huffman CJ, et al.
Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses.
J Virol. 2012.
PubMed - Related Articles
Abstract available
Ault A, Zajac AM, Kong WP, Gorres JP, et al.
Immunogenicity and clinical protection against equine influenza by gene-based DNA vaccination of ponies.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Zhou B, Li Y, Speer SD, Subba A, et al.
Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Wagner R, Gopfert C, Hammann J, Neumann B, et al.
Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-An effective EU regulatory approach.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Hatz C, von Sonnenburg F, Casula D, Lattanzi M, et al.
A randomized clinical trial to identify the optimal antigen and MF59((R)) adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Baguelin M, Jit M, Miller E, Edmunds WJ, et al.
Health and economic impact of the seasonal influenza vaccination programme in England.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Lu PJ, Dorell C, Yankey D, Santibanez TA, et al.
A comparison of parent and provider reported influenza vaccination status of adolescents.
Vaccine. 2012.
PubMed - Related Articles
Abstract available
Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, et al.
Safety of pandemic H1N1 vaccines in children and adolescents.
Vaccine. 2011.
PubMed - Related Articles
Abstract available
-
-------
Research Articles Abstracts ? April 9 2012 Issue
Research Articles Abstracts ? April 9 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts ? April 9 2012 Issue
Abstracts List
Theisen LL, Muller CP.
EPs(R) 7630 (Umckaloabo(R)), an extract from Pelargonium sidoides roots, exerts anti-influenza virus activity in vitro and in vivo.
Pepin KM, Riley S, Grenfell BT.
Effects of influenza antivirals on individual and population immunity over many epidemic waves.
Wortham BW, Eppert BL, Motz GT, Flury JL, et al.
NKG2D Mediates NK Cell Hyperresponsiveness and Influenza-Induced Pathologies in a Mouse Model of Chronic Obstructive Pulmonary Disease.
Fedson D.
Influenza vaccination or treatment for influenza-associated myocardial infaction.
Dobrikova EY, Goetz C, Walters RW, Lawson SK, et al.
Attenuation of neurovirulence, biodistribution, and shedding of a poliovirus:rhinovirus chimera after intrathalamic inoculation in Macaca fascicularis.
.. .
Influenza outbreaks at two correctional facilities - maine, march 2011.
Muratore G, Goracci L, Mercorelli B, Foeglein A, et al.
Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase.
Ehrlich HJ, Muller M, Kollaritsch H, Pinl F, et al.
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Thompson MG, Gaglani MJ, Naleway A, Ball S, et al.
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel.
Jimenez-Jorge S, Savulescu C, Pozo F, de Mateo S, et al.
Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
Fukase H, Furuie H, Yasuda Y, Komatsu R, et al.
Assessment of the immunogenicity and safety of varying doses of an MF59((R))-adjuvanted cell culture-derived A/H1N1 pandemic influenza vaccine in Japanese paediatric, adult and elderly subjects.
Langley JM, Scheifele DW, Quach C, Vanderkooi OG, et al.
Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study.
Schmeisser F, Adamo JE, Blumberg B, Friedman R, et al.
Production and characterization of mammalian virus-like particles from modified vaccinia virus Ankara vectors expressing influenza H5N1 hemagglutinin and neuraminidase.
Rockman S, Middleton DJ, Pearse MJ, Barr IG, et al.
Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines.
Rudneva I, Ignatieva A, Timofeeva T, Shilov A, et al.
Escape mutants of pandemic influenza A/H1N1 2009 virus: Variations in antigenic specificity and receptor affinity of the hemagglutinin.
-
-------
Research Articles Abstracts ? April 14 2012 Issue
Research Articles Abstracts ? April 14 2012 Issue
[Source: AMEDEO, homepage:
http://www.amedeo.com/ ]
Research Articles Abstracts ? April 14 2012 Issue
Abstracts List
Kim A, Lee JY, Byun SJ, Kwon MH, et al.
Viral genome RNA degradation by sequence-selective, nucleic-acid hydrolyzing antibody inhibits the replication of influenza H9N2 virus without significant cytotoxicity to host cells.
McGrath LJ, Kshirsagar AV, Cole SR, Wang L, et al.
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment.
Janjua NZ, Skowronski DM, De Serres G, Dickinson J, et al.
Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: Cross protection against major and minor variants.
Zhang Y, Sun Y, Sun H, Pu J, et al.
A Single Amino Acid at the Hemagglutinin Cleavage Site Contributes to the Pathogenicity and Neurovirulence of H5N1 Influenza Virus in Mice.
Ng AK, Lam MK, Zhang H, Liu J, et al.
Structural basis for RNA-binding and homo-oligomer formation by influenza B virus nucleoprotein.
Brown DM, Lee S, Garcia-Hernandez MD, Swain SL, et al.
Multi-functional CD4 cells expressing IFN-gamma and perforin mediate protection against lethal influenza infection.
Khatri M, Goyal SM, Saif YM.
Oct4+ stem/progenitor swine lung epithelial cells are targets for influenza virus replication.
Kitikoon P, Vincent AL, Gauger PC, Schlink SN, et al.
Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011.
Shinya K, Gao Y, Cilloniz C, Suzuki Y, et al.
Integrated Clinical, Pathologic, Virologic, and Transcriptomic Analysis of H5N1 Influenza Virus-Induced Viral Pneumonia in the Rhesus Macaque.
.. .
Antibodies Cross-Reactive to Influenza A (H3N2) Variant Virus and Impact of 2010-11 Seasonal Influenza Vaccine on Cross-Reactive Antibodies - United States.
Magro M, Mas V, Chappell K, Vazquez M, et al.
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.
Talbot HK, Coleman LA, Crimin K, Zhu Y, et al.
Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.
Robichaud P, Hawken S, Beard L, Morra D, et al.
Vaccine-critical videos on YouTube and their impact on medical students' attitudes about seasonal influenza immunization: A pre and post study.
Shafique M, Wilschut J, de Haan A.
Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
-
------
Research Articles Abstracts?April 21 2012 Issue
Research Articles Abstracts?April 21 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?April 21 2012 Issue
Abstracts List
Tan AC, Eriksson EM, Kedzierska K, Deliyannis G, et al.
Polyfunctional CD8(+) T cells are associated with the vaccination-induced control of a novel recombinant influenza virus expressing an HCV epitope.
Katz LM.
How can the blood transfusion medicine community contribute to public health in tough economic times?
Do LA, van Doorn HR, Bryant JE, Nghiem MN, et al.
A sensitive real-time PCR for detection and subgrouping of human respiratory syncytial virus.
Kikuchi T, Iwatsuki-Horimoto K, Adachi E, Koga M, et al.
Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults.
-
------
Research Articles Abstracts?April 28 2012 Issue
Research Articles Abstracts?April 28 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?April 28 2012 Issue
Abstracts List
Zu M, Yang F, Zhou W, Liu A, et al.
In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Soilly AL, Ferdynus C, Desplanches O, Grimaldi M, et al.
Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme.
Spaeder MC, Fackler JC.
A multi-tiered time-series modelling approach to forecasting respiratory syncytial virus incidence at the local level.
Higgins RR, Beniprashad M, Chong-King E, Li Y, et al.
Recovery of Influenza B Virus with the H273Y Point Mutation in the neuraminidase Active site from a Human Patient.
Bodewes R, Nieuwkoop NJ, Verburgh RJ, Fouchier RA, et al.
The use of influenza A viruses expressing reporter genes to assess the frequency of double infections in vitro.
Li M, Brenwald N, Bonigal S, Chana K, et al.
Rapid Diagnosis Of Influenza: An Evaluation Of Two Commercially Available Rt-Pcr Assays.
Mamelund SE.
Fertility Fluctuations in Times of War and Pandemic Influenza.
Widmer K, Zhu Y, Williams JV, Griffin MR, et al.
Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older Adults.
Josset L, Belser JA, Pantin-Jackwood MJ, Chang JH, et al.
Implication of inflammatory macrophages, nuclear receptors and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation.
Bouvier NM, Rahmat S, Pica N.
Enhanced Mammalian Transmissibility of Seasonal Influenza A/H1N1 Viruses Encoding an Oseltamivir-Resistant Neuraminidase.
Gao Q, Chou YY, Doganay S, Vafabakhsh R, et al.
The influenza A virus PB2, PA, NP and M segments play a pivotal role during genome packaging.
Marklund JK, Ye Q, Dong J, Tao YJ, et al.
Sequence in the Influenza A Virus Nucleoprotein Required for Viral Polymerase Binding and RNA Synthesis.
Elsner RA, Ernst DN, Baumgarth N.
Single and co-expression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza infection.
Stockwell MS, Kharbanda EO, Martinez RA, Vargas CY, et al.
Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial.
.. .
Severe Coinfection with Seasonal Influenza A (H3N2) Virus and Staphylococcus aureus - Maryland, February-March 2012.
de Vries E, de Vries RP, Wienholts MJ, Floris CE, et al.
Influenza A virus entry into cells lacking sialylated N-glycans.
St Paul M, Mallick AI, Read LR, Villanueva AI, et al.
Prophylactic treatment with Toll-like receptor ligands enhances host immunity to avian influenza virus in chickens.
Lu AB, Halim AA, Dendle C, Kotsanas D, et al.
Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal.
-
------
Research Articles Abstracts?May 5 2012 Issue
Research Articles Abstracts?May 5 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?May 5 2012 Issue
Abstracts List
Inglesby TV.
Engineered H5N1: a rare time for restraint in science.
Wang X, Zhang W, Liu F, Zheng M, et al.
Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
Knight M, Lim B.
Immunisation against influenza during pregnancy.
Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.
Cohen D.
Questions remain over safety and effectiveness of oseltamivir.
Cohen D.
Search for evidence goes on.
Doshi P, Jones M, Jefferson T.
Rethinking credible evidence synthesis.
Zhou F, Zhou J, Ma L, Song S, et al.
High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
Chen R, Mias GI, Li-Pook-Than J, Jiang L, et al.
Personal omics profiling reveals dynamic molecular and medical phenotypes.
Harvala H, Gaunt E, McIntyre C, Roddie H, et al.
Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit.
Hadler JL, Baker TN, Papadouka V, France AM, et al.
Effectiveness of One Dose of 2009 Influenza A (H1N1) Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza in Children 7 Months to 9 Years of Age.
Pearce MB, Belser JA, Gustin KM, Pappas C, et al.
Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus in Ferrets.
Szilagyi PG, Adams WG.
Text messaging: a new tool for improving preventive services.
Kuehn BM.
US reviews high-risk research portfolio.
Osterholm MT, Kelley NS.
H5N1 influenza virus seroepidemiological studies: The facts revisited.
Chou YY, Vafabakhsh R, Doganay S, Gao Q, et al.
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis.
Li X, Miao H, Henn A, Topham DJ, et al.
Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination.
Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, et al.
Indirect, out-of-pocket and medical costs from influenza-related illness in young children.
Gomez Y, Leguen F, Zhang G, O'Connell E, et al.
Correlates of 2009 H1N1 influenza vaccination among day care-aged children, Miami-Dade County.
Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, et al.
How influenza vaccination policy may affect vaccine logistics.
Reperant LA, Kuiken T, Osterhaus AD.
Adaptive pathways of zoonotic influenza viruses: From exposure to establishment in humans.
Frew PM, Painter JE, Hixson B, Kulb C, et al.
Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.
de Haan A, Haijema BJ, Voorn P, Meijerhof T, et al.
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
Jones BG, Sealy R, Rudraraju R, Traina-Dorge V, et al.
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
Lima HN, Botosso VF, Oliveira DB, Campos AC, et al.
Molecular epidemiology of the SH (small hydrophobic) gene of human respiratory syncytial virus (HRSV), over 2 consecutive years.
Lott J, Johnson J.
Promising Practices for School-located Vaccination Clinics--: Part II: Clinic Operations and Program Sustainability.
Lott J, Johnson J.
Promising Practices for School-located Vaccination Clinics--Part I: Preparation.
-
-------
Research Articles Abstracts?May 12 2012 Issue
Research Articles Abstracts?May 12 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?May 12 2012 Issue
Abstracts List
Inglesby TV.
Engineered H5N1: a rare time for restraint in science.
Wang X, Zhang W, Liu F, Zheng M, et al.
Intranasal immunization with live attenuated influenza vaccine plus chitosan as an adjuvant protects mice against homologous and heterologous virus challenge.
Knight M, Lim B.
Immunisation against influenza during pregnancy.
Pasternak B, Svanstrom H, Molgaard-Nielsen D, Krause TG, et al.
Vaccination against pandemic A/H1N1 2009 influenza in pregnancy and risk of fetal death: cohort study in Denmark.
Cohen D.
Questions remain over safety and effectiveness of oseltamivir.
Cohen D.
Search for evidence goes on.
Doshi P, Jones M, Jefferson T.
Rethinking credible evidence synthesis.
Zhou F, Zhou J, Ma L, Song S, et al.
High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
Chen R, Mias GI, Li-Pook-Than J, Jiang L, et al.
Personal omics profiling reveals dynamic molecular and medical phenotypes.
Harvala H, Gaunt E, McIntyre C, Roddie H, et al.
Epidemiology and clinical characteristics of parainfluenza virus 3 outbreak in a Haemato-oncology unit.
Hadler JL, Baker TN, Papadouka V, France AM, et al.
Effectiveness of One Dose of 2009 Influenza A (H1N1) Vaccine at Preventing Hospitalization with Pandemic H1N1 Influenza in Children 7 Months to 9 Years of Age.
Pearce MB, Belser JA, Gustin KM, Pappas C, et al.
Seasonal Trivalent Inactivated Influenza Vaccine Protects against 1918 Spanish Influenza Virus in Ferrets.
Szilagyi PG, Adams WG.
Text messaging: a new tool for improving preventive services.
Kuehn BM.
US reviews high-risk research portfolio.
Osterholm MT, Kelley NS.
H5N1 influenza virus seroepidemiological studies: The facts revisited.
Chou YY, Vafabakhsh R, Doganay S, Gao Q, et al.
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis.
Li X, Miao H, Henn A, Topham DJ, et al.
Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination.
Ortega-Sanchez IR, Molinari NA, Fairbrother G, Szilagyi PG, et al.
Indirect, out-of-pocket and medical costs from influenza-related illness in young children.
Gomez Y, Leguen F, Zhang G, O'Connell E, et al.
Correlates of 2009 H1N1 influenza vaccination among day care-aged children, Miami-Dade County.
Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, et al.
How influenza vaccination policy may affect vaccine logistics.
Reperant LA, Kuiken T, Osterhaus AD.
Adaptive pathways of zoonotic influenza viruses: From exposure to establishment in humans.
Frew PM, Painter JE, Hixson B, Kulb C, et al.
Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.
de Haan A, Haijema BJ, Voorn P, Meijerhof T, et al.
Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
Jones BG, Sealy R, Rudraraju R, Traina-Dorge V, et al.
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection.
Lima HN, Botosso VF, Oliveira DB, Campos AC, et al.
Molecular epidemiology of the SH (small hydrophobic) gene of human respiratory syncytial virus (HRSV), over 2 consecutive years.
Lott J, Johnson J.
Promising Practices for School-located Vaccination Clinics--: Part II: Clinic Operations and Program Sustainability.
Lott J, Johnson J.
Promising Practices for School-located Vaccination Clinics--Part I: Preparation.
-
-------
Research Articles Abstracts?May 19 2012 Issue
Research Articles Abstracts?May 19 2012 Issue
[Source: AMEDEO, homepage: (
LINK ).]
Research Articles Abstracts?May 19 2012 Issue
Abstracts List
VAN BORM S, Rosseel T, Vangeluwe D, Vandenbussche F, et al.
Phylogeographic analysis of avian influenza viruses isolated from Charadriiformes in Belgium confirms intercontinental reassortment in gulls.
BIDOKHTI MR, Traven M, Ohlson A, Zarnegar B, et al.
Phylogenetic analysis of bovine respiratory syncytial viruses from recent outbreaks in feedlot and dairy cattle herds.
PONNAMBALAM L, Samavedham L, Lee HR, Ho CS, et al.
Understanding the socioeconomic heterogeneity in healthcare in US counties: the effect of population density, education and poverty on H1N1 pandemic mortality.
LEUNG YH, Lim WL, Wong MH, Chuang SK, et al.
Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
PING J, Selman M, Tyler S, Forbes N, et al.
Low pathogenic avian influenza virus A/Turkey/Ontario/6213/1966(H5N1) is the progenitor of highly pathogenic A/Turkey/Ontario/7732/1966(H5N9).
HELDT FS, Frensing T, Reichl U.
Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.
SHAW A.
New technologies for new influenza vaccines.
TOH MP, Kannan P, Chen Y, Chng FL, et al.
Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference?
XU J, Huang D, Liu S, Lin H, et al.
Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs.
CAMPITELLI MA, Inoue M, Calzavara AJ, Kwong JC, et al.
Low Rates of Influenza Immunization in Young Children Under Ontario's Universal Influenza Immunization Program.
Pediatrics. 2012.
PubMed: www.amedeo.com/p2.php?id=22585770&s=flu&pm=2
ABSTRACT available
Share: http://hub.amedeo.com/22585770
We have screened the following journals for you:
Am J Med
Ann Intern Med
Antimicrob Agents Chemother
Antiviral Res
Arch Intern Med
Arch Virol
Biochem Biophys Res Commun
Biochem Soc Trans
Biochemistry
BMJ
Cell
Clin Diagn Lab Immunol
Commun Dis Rep CDR Wkly
Drug Saf
Drugs
Epidemiol Infect
Eur J Epidemiol
J Clin Microbiol
J Epidemiol Community Health
J Exp Med
J Gen Virol
J Immunol
J Infect
J Infect Dis
J Virol
J Virol Methods
JAMA
Lancet
MMWR Morb Mortal Wkly Rep
N Engl J Med
Pediatrics
Proc Natl Acad Sci U S A
Vaccine
Virology
Virus Res
-
-------